NCT00250211View on ClinicalTrials.gov

Magnetic Resonance Spectroscopic Imaging (MRS) and Tumor Perfusion of Human Glioblastoma Treated With Concurrent Radiation Therapy and Temozolomide

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

March 31, 2011

Study Completion Date

April 30, 2011

Conditions
GlioblastomaGlioma
Interventions
PROCEDURE

Functional MRI imaging and tomotherapy

Trial Locations (1)

T6G 1Z2

Cross Cancer Institute, Edmonton

All Listed Sponsors
collaborator

Cross Cancer Institute

OTHER

lead

AHS Cancer Control Alberta

OTHER

NCT00250211 - Magnetic Resonance Spectroscopic Imaging (MRS) and Tumor Perfusion of Human Glioblastoma Treated With Concurrent Radiation Therapy and Temozolomide | Biotech Hunter | Biotech Hunter